Herbert Stadler,2 and
Peter Löser1,
DeveloGen AG NL Berlin, Robert-Rössle-Strasse 10, D-13125 Berlin, Germany,1 Affectis Pharmaceuticals AG, Kraepelinstrasse 2, D-80804 Munich, Germany2
Received 31 January 2006/ Accepted 13 March 2006
We here describe a convenient system for the production of recombinant
adenovirus vectors and its use for the construction of a representative
adenovirus-based cDNA expression library. The system is based on direct
site-specific insertion of transgene cassettes into a replicating donor
virus. The transgene is inserted into a donor plasmid containing the
viral 5' inverted terminal repeat, the complete viral packaging
signal, and a single loxP site. The plasmid is then
transfected into a Cre recombinase-expressing packaging cell line that
has been infected with a donor virus containing a partially deleted
packaging signal flanked by loxP sites. Cre recombinase, by
two steps of action, sequentially catalyzes the generation of a
nonpackageable donor virus acceptor substrate and the generation of the
desired recombinant adenovirus vector. Due to its growth impairment,
residual donor virus can efficiently be counterselected during
amplification of the recombinant adenovirus vector. By using this
adenovirus construction system, a plasmid-based human liver cDNA
library was converted by a single step into an adenovirus-based cDNA
expression library with about 106 independent adenovirus
clones. The high-titer purified library was shown to contain about 44%
of full-length cDNAs with an average insert size of 1.3 kb. cDNAs of a
gene expressed at a high level (human
1-antitrypsin) and a gene expressed at a relatively
low level (human coagulation factor IX) in human liver were isolated
from the adenovirus-based library using an enzyme-linked immunosorbent
assay-based screening procedure.
Present
address: Apit Laboratories GmbH, Hermanswerder 16, D-14473 Potsdam, Germany.
Present
address: Robert-Koch-Institut, Seestr. 10, D-13353 Berlin, Germany.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|